Luís Miguel de Sande

Combination chemotherapy with cisplatin and 5-fluorouracil 5-day infusion in the therapy of advanced gastric cancer: A Phase II trial

Ángel J. Lacave, L. M. Antón, Enrique Estrada et al. · Annals of Oncology · 1991 · 96 citations · Full text

Medicine, Oncology, Pharmacology +11

Prognostic time dependence of deletions affecting codons 557 and/or 558 of KIT gene for relapse-free survival (RFS) in localized GIST: a Spanish Group for Sarcoma Research (GEIS) Study

Javier Martín‐Broto, Antonio Gutiérrez, José Antonio López‐Guerrero et al. · Annals of Oncology · 2010 · 72 citations

Medicine, Genetics, Oncology +11

Relevance of Reference Centers in Sarcoma Care and Quality Item Evaluation: Results from the Prospective Registry of the Spanish Group for Research in Sarcoma (GEIS)

Javier Martín‐Broto, Nadia Hindi, Josefina Cruz et al. · The Oncologist · 2018 · 61 citations · Full text

Medicine, Oncology, Surgery +17

Cost-minimisation analysis of pegylated liposomal doxorubicin hydrochloride versus topotecan in the treatment of patients with recurrent epithelial ovarian cancer in Spain

B. Ojeda, Luís Miguel de Sande, Antonio Casado et al. · British Journal of Cancer · 2003 · 46 citations · Full text

Pharmacy, Pharmacoeconomics, Pharmacotherapy +17

Atezolizumab Combined With Platinum and Maintenance Niraparib for Recurrent Ovarian Cancer With a Platinum-Free Interval >6 Months: ENGOT-OV41/GEICO 69-O/ANITA Phase III Trial

Antonio González-Martı́n, María Jesús Rubio, Florian Heitz et al. · Journal of Clinical Oncology · 2024 · 25 citations · Full text

Medicine, Oncology, Pharmacotherapy +16